Navigation Links
VCU Medical Center leads study of first US portable driver for powering the total artificial heart

RICHMOND, Va. (Sept. 9, 2010) The Virginia Commonwealth University Medical Center is the lead institution in a national clinical trial of technology that will allow artificial heart patients to recuperate, rehabilitate and wait in the comfort of their own homes until a donor heart becomes available for transplant.

The VCU Pauley Heart Center is one of up to 30 centers that will investigate a portable, mechanical driver that can power patients' artificial hearts and enable them to recover outside the hospital environment, including at home and at step-down facilities.

"This is the kind of technology that changes lives," said John Duval, CEO of MCV Hospitals at the VCU Medical Center. "VCU has long been a leader in heart-assist technology, pioneering the implantation of the first Total Artificial Heart on the East Coast in 2006.

"This portable driver, if successful, will allow patients who once had to spend months, and sometimes more than a year in the hospital waiting for a donor heart, to recuperate in the comfort of their own homes," Duval said.

The VCU Medical Center received institutional review board approval in early September to participate in an Investigational Device Exemption (IDE) clinical study of the Freedom driver, the first-ever U.S. portable driver designed to power SynCardia's Total Artificial Heart both inside and outside the hospital. The IDE clinical study is intended to demonstrate that the Freedom driver is a suitable pneumatic driver for stable Total Artificial Heart patients and can be used safely at home.

"Prior to this, everyone who was placed on a Total Artificial Heart had to remain in the hospital until they underwent transplantation," said Michael Hess, M.D., director of the VCU Pauley Heart Center advanced heart failure transplantation program. "The reason for this is that the only FDA-approved driver system for powering the Total Artificial Heart is a 418-pound console.

"Now this driver thanks to advances in engineering is 13 and a half pounds and can be worn in a backpack, and we will be able to discharge stable patients away from the hospital to await their transplant," Hess said.

The SynCardia Total Artificial Heart currently used at the VCU Medical Center is approved as a bridge to human heart transplant for patients dying from end-stage biventricular failure.

The portable driver features two onboard lithium-ion batteries and a power adaptor. It is designed to be carried by the patient in a backpack or shoulder bag. Another participating medical center, Mayo Clinic Arizona, discharged a patient with the driver in May.

Vigneshwar Kasirajan, M.D., chair of cardiothoracic surgery and director of the Pauley Heart Center's heart transplantation program, said he anticipates a two-to-three week period from the time of implant to switchover to the driver and then two weeks to discharge.

"We have already talked with some of our patients about potentially being able to go home with a driver and a lot of the patients are excited by it the possibility they could actually go home while they're waiting for a transplant," Kasirajan said. "Right now the average waiting time for a transplant is about three months for patients with the artificial heart, so I think for patients, it's a great opportunity to be able to go home."

The clinical trial is approved to enroll 60 patients. The VCU Medical Center has one of the best success rates in the country in artificial heart implants, with an approximate 85 percent survival rate among patients since 2006.


Contact: Anne Buckley
Virginia Commonwealth University

Related medicine news :

1. Research demonstrates benefits of medical cannabis as a treatment for chronic pain
2. Radiologists call for national strategy to address medical imaging overuse
3. NIH renews research program to develop medical countermeasures against radiological, nuclear threats
4. U-Ms efforts to encourage disclosure of medical errors decreased claims
5. How badly does it hurt? Research examines the biomedical diagnosis of pain
6. Speed electronic medical record adoption via key medical centers, says Management Science
7. More Than 70,000 Kids Injured By Medical Devices Each Year
8. Childrens National Medical Center receives first NIH CTSA given to a childrens hospital
9. University of Mississippi Medical Center to lead in nationwide NIH-funded Alzheimers study
10. New online community launched to help medical practices learn about meaningful use
11. RMSR Certification Gains Medical Device & Equipment Industry Acceptance for Medical Sales Reps
Post Your Comments:
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent Applied ... the need to integrate dose form selection in early phase drug development. The ... organization supporting and bringing together the UK’s emerging life sciences companies, corporate partners, ...
(Date:11/26/2015)... ... 26, 2015 , ... Pixel Film Studios brings Final Cut ... Vintage. This newly styled ProTrailer pack comes with 30 all-new vintage-inspired designs, with ... users limitless opportunities to stylize and create designs quickly and easily, all within ...
(Date:11/25/2015)... ... November 25, 2015 , ... As part of ... Empowerment ™ attracts volunteers together who want to combine talents and resources to ... stakeholders in the process. The non-profit launched its first major fundraiser on November ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... factory direct sauna parts and accessories. , Sauna accessories help improve the bather ... style and personality. From basic styles for the purist looking for simplicity in ...
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert is donating ... Beat ” campaign. The partnership between the two groups began in 2014 with Vitalalert ... cause. , MAP International was founded in 1954 and is an international Christian-based health ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... November 26, 2015 --> ... combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced ... approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... has found that immunotherapy can be efficiently combined with ...
(Date:11/26/2015)... -- 3D bioprinting market is expected to ... report by Grand View Research Inc. Rising prevalence of chronic ... transplantation is expected to boost the market growth, as 3D ... --> 3D bioprinting market is expected to ... report by Grand View Research Inc. Rising prevalence of chronic ...
(Date:11/26/2015)... ) has ... Future Horizons and Growth Strategies in the ... Shares, Country Segment Forecasts, Competitive Intelligence, Emerging ... --> ) has announced the ... and Growth Strategies in the German Drugs ...
Breaking Medicine Technology: